Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 27 Apr 2026 for Amicus Therapeutics, INC., €2.7M. Read the official filing
Filing timeline
BuySaleDavid Michael Clark
Insider track record
Disclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
David Michael Clark: trading record in brief
All filings by David Michael Clark on record concern Amicus Therapeutics, Inc., in the capacity of senior executive. The record holds 26 filings, for trades running from 9 October 2021 to 27 April 2026.
Every open-market trade on record is a sale: 9 sales worth €1.4M. Other entries cover 16 share grants.
Most recently, on 27 April 2026, the filings show a transaction worth €2.7M in Amicus Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Michael Clark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
221,811 shares@ US$14.500.069% mcap62.0% of flowCommon StockSEC:0001193125-26-182254:0
5,381 shares@ US$14.273.9% of flowCommon StockSEC:0001193125-26-005043:0
18,498 shares@ US$14.2713.3% of flowCommon StockSEC:0001193125-26-005043:1
25,642 shares@ US$14.171318.4% of flowCommon StockSEC:0001193125-25-330954:0
25,643 shares@ US$11.004.8% of flowCommon StockSEC:0001193125-25-323147:0
25,643 shares@ US$10.09764.8% of flowCommon StockSEC:0001193125-25-301019:0
25,643 shares@ US$9.50984.7% of flowCommon StockSEC:0001193125-25-266900:0
52,338 shares0Common StockSEC:0000950170-25-020037:0
5,381 shares@ US$9.312.9% of flowCommon StockSEC:0000950170-25-002426:0
13,684 shares0Common StockSEC:0000950170-24-032405:0
4,427 shares@ US$14.003.4% of flowCommon StockSEC:0000950170-24-017265:0
8,614 shares@ US$13.656.4% of flowCommon StockSEC:0000950170-24-004045:0
8,726 shares@ US$14.006.6% of flowCommon StockSEC:0000950170-24-003441:0
1,384 shares@ US$14.001.1% of flowCommon StockSEC:0000950170-24-003441:1
2,692 shares@ US$13.442.0% of flowCommon StockSEC:0000950170-24-002580:0
48,209 shares0Common StockSEC:0000950170-24-002116:0
8,212 shares0Common StockSEC:0000950170-23-071629:0
7,382 shares@ US$13.505.5% of flowCommon StockSEC:0001209191-23-004082:0
47,621 shares0Common StockSEC:0001209191-23-003304:0
2,692 shares@ US$12.031.8% of flowCommon StockSEC:0001209191-23-002393:0
11,336 shares@ US$12.217.7% of flowCommon StockSEC:0001209191-23-001404:0
5,510 shares@ US$10.403.5% of flowCommon StockSEC:0001209191-22-053396:0
11,322 shares@ US$12.508.2% of flowCommon StockSEC:0001209191-22-045059:0
59,071 sharesCommon StockSEC:0001209191-22-003826:0
7,280 shares@ US$11.551.5% of flowCommon StockSEC:0001209191-22-001237:0
25 of 26 declarations
